Abstract:Background: International health policies and researchers have emphasized the value of evaluating patient-reported outcomes (PROs) in clinical studies. However, the characteristics of PROs in adult tumor clinical trials in China remain insufficiently elucidated. Objective: This study aims to assess the application and characteristics of PRO instruments as primary or secondary outcomes in adult randomized clinical trials related to tumors in China. Methods: This cross-sectional study identified tumor-focused randomized clinical trials conducted in China between January 1, 2010, and June 30, 2022. The ClinicalTrials.gov database and the Chinese Clinical Trial Registry were selected as the databases. Trials were classified into four groups based on the use of PRO instruments: (1) trials listing PRO instruments as primary outcomes, (2) trials listing PRO instruments as secondary outcomes, (3) trials listing PRO instruments as coprimary outcomes, and (4) trials without any mention of PRO instruments. Pertinent data, including study phase, settings, geographic regions, centers, participant demographics (age and sex), funding sources, intervention types, target diseases, and the names of PRO instruments, were extracted from these trials. The target diseases involved in the trials were grouped according to the American Joint Committee on Cancer Staging Manual, 8th Edition. Results: Among the 6445 trials examined, 2390 (37.08%) incorporated PRO instruments as part of their outcomes. Within this subset, 26.82% (641/2390) listed PRO instruments as primary outcomes, 52.72% (1260/2390) as secondary outcomes, and 20.46% (489/2390) as coprimary outcomes. Among the 2,155,306 participants included in these trials, PRO instruments were used to collect data from 613,648 (28.47%) patients as primary or secondary outcomes and from 74,287 (3.45%) patients as coprimary outcomes. The most common conditions explicitly using specified PRO instruments included thorax tumors (217/1280, 16.95%), breast tumors (176/1280, 13.75%), and lower gastrointestinal tract tumors (173/1280, 13.52%). Frequently used PRO instruments included the European Organisation for Research and Treatment of Cancer Quality of Life Core Questionnaire-30, the visual analog scale, the numeric rating scale, the Traditional Chinese Medicine Symptom Scale, and the Pittsburgh Sleep Quality Index. Conclusions: Over recent years, the incorporation of PROs has demonstrated an upward trajectory in adult randomized clinical trials on tumors in China. Nonetheless, the infrequent measurement of the patient's voice remains noteworthy. Disease-specific PRO instruments should be more effectively incorporated into various tumor disease categories in clinical trials, and there is room for improvement in the inclusion of PRO instruments as clinical trial end points.

The use of dental patient-reported outcomes (dPROs) in prediction modeling studies in oral health: A methodological review

Systematic Review of Prognosis Models in Predicting Tooth Loss in Periodontitis

Examining Bias and Reporting in Oral Health Prediction Modeling Studies

THE VOICE OF THE PATIENT IN OROFACIAL PAIN MANAGEMENT

Using Patient-Reported Outcomes in Dose-Finding Oncology Trials: Surveys of Key Stakeholders and the National Cancer Research Institute Consumer Forum

Developing Machine Learning Algorithms Incorporating Patient Reported Outcomes to Predict Disease Progression in Head and Neck Cancers

The use of patient-reported outcomes in routine cancer care: preliminary insights from a multinational scoping survey of oncology practitioners

Comparison of Predictive Properties between Tools of Patient-Reported Outcomes: Risk Prediction for Three Future Events in Subjects with COPD

The development of a new oral health patient reported outcome measure: the New South Wales public dental services approach

The Prognostic Significance of Patient-Reported Outcomes in Cancer Clinical Trials

Impact of Measuring Patient-Reported Outcomes in Dermatology Drug Development

Development and International Validation of Logistic Regression and Machine-Learning Models for the Prediction of 10-Year Molar Loss

Utilization of Patient Reported Outcome Measures in Plastic Surgery Clinical Trials: A Systematic Review

Social determinants of health in prognostic machine learning models for orthopaedic outcomes: A systematic review

Prognostic factors affecting the short-term efficacy of non-surgical treatment of chronic periodontitis: a multilevel modeling analysis

Clinical use of digital applications for diagnostic and treatment planning in prosthodontics: A scoping review

Patient-Reported Outcomes as Interradiographic Predictors of Response in Non-Small Cell Lung Cancer

Linking patient-reported oral and general health-related quality of life

Deep Learning Improves Prediction of Periodontal Therapy Effectiveness in Chinese Patients.

Application of Patient-Reported Outcome Measurements in Adult Tumor Clinical Trials in China: Cross-Sectional Study

Integration of Patient Reported Quality-of-life Data into Risk Assessment in Heart Failure